Clinical Trials Of Hepatitis C Treatments Show Success

News outlets examine recently released clinical trial results of hepatitis C treatments.

Financial Times: Drug groups step up race for hepatitis C treatments
“Drugmakers are stepping up the race for multibillion-dollar hepatitis C treatments after trial data showed how the disease had become one of the most promising areas of drug development…” (Ward, 4/13).

Los Angeles Times: New drugs provide cure for hepatitis C, research finds
“…In a series of clinical trial results, a new generation of antiviral medications was able to clear the liver-ravaging virus from virtually all patients’ bloodstreams in as little as eight weeks. Even in patients with the most stubborn infections, the new drugs were capable of suppressing the virus completely at rates well over 90 percent. The treatments, however, come with a steep price tag…” (Healy, 4/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.